These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16404786)

  • 1. Possible antipsychotic effect of fluvoxamine.
    Goldman S
    CNS Spectr; 2005 Oct; 10(10):774; author reply 774-5. PubMed ID: 16404786
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetic ketoacidosis associated with risperidone treatment?
    Croarkin PE; Jacobs KM; Bain BK
    Psychosomatics; 2000; 41(4):369-70. PubMed ID: 10906363
    [No Abstract]   [Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled trial of long-acting risperidone in cocaine-dependent men.
    Loebl T; Angarita GA; Pachas GN; Huang KL; Lee SH; Nino J; Logvinenko T; Culhane MA; Evins AE
    J Clin Psychiatry; 2008 Mar; 69(3):480-6. PubMed ID: 18294021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risperidone long-acting therapy prescribing patterns and their impact on early discontinuation of treatment in a large Medicaid population.
    Boaz TL; Constantine RJ; Robst J; Becker MA; Howe AM
    J Clin Psychiatry; 2011 Aug; 72(8):1079-85. PubMed ID: 21034690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and tolerability of long-acting intramuscular risperidone as adjuvant treatment in refractory borderline personality disorder.
    Carrasco JL; Palomares N; Marsá MD
    Psychopharmacology (Berl); 2012 Nov; 224(2):347-8. PubMed ID: 23052570
    [No Abstract]   [Full Text] [Related]  

  • 6. Risperidone long-acting injection in practice - more questions than answers?
    Taylor D
    Acta Psychiatr Scand; 2006 Jul; 114(1):1-2. PubMed ID: 16774654
    [No Abstract]   [Full Text] [Related]  

  • 7. Risperidone and tardive dyskinesia: a case report.
    Addington DE; Toews JA; Addington JM
    J Clin Psychiatry; 1995 Oct; 56(10):484-5. PubMed ID: 7559377
    [No Abstract]   [Full Text] [Related]  

  • 8. Switch to quetiapine in antipsychotic agent-related hyperprolactinemia.
    Keller R; Mongini F
    Neurol Sci; 2002 Dec; 23(5):233-5. PubMed ID: 12522680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social and clinical descriptors of antipsychotic prescription.
    Piccinni C; Piazza A; Poluzzi E; Tarricone I; Koci A; Berardi D; Fioritti A; de Ponti F
    Int J Psychiatry Med; 2015; 49(1):45-62. PubMed ID: 25838320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exacerbation of idiopathic priapism with risperidone-citalopram combination.
    Freudenreich O
    J Clin Psychiatry; 2002 Mar; 63(3):249-50. PubMed ID: 11926728
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety and efficacy of risperidone in substance abusers with psychosis.
    Albanese MJ
    Am J Addict; 2001; 10(2):190-1. PubMed ID: 11444160
    [No Abstract]   [Full Text] [Related]  

  • 12. Carbamazepine and/or fluvoxamine drug interaction with risperidone in a patient on multiple psychotropic medications.
    Alfaro CL; Nicolson R; Lenane M; Rapoport JL
    Ann Pharmacother; 2000 Jan; 34(1):122-3. PubMed ID: 10669197
    [No Abstract]   [Full Text] [Related]  

  • 13. Risperidone-induced hyperprolactinemia in adolescents: A case series.
    Madhusoodanan S; Moise D
    J Clin Psychiatry; 2006 Jul; 67(7):1110-3. PubMed ID: 16889455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deliberate self-poisoning following fluvoxamine-neuroleptics combination.
    Chong SA; Cheong A
    J Clin Psychiatry; 1999 Dec; 60(12):869. PubMed ID: 10665638
    [No Abstract]   [Full Text] [Related]  

  • 15. Priapism associated with polypharmacy.
    Seger A; Lamberti JS
    J Clin Psychiatry; 2001 Feb; 62(2):128. PubMed ID: 11247100
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-acting injectable risperidone in treatment refractory patients: a 14-week open-label pilot study.
    Procyshyn RM; Barr AM; Flynn S; Schenk C; Ganesan S; Honer WG
    Schizophr Res; 2010 Nov; 123(2-3):273-5. PubMed ID: 20688481
    [No Abstract]   [Full Text] [Related]  

  • 17. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
    Erzegovesi S; Guglielmo E; Siliprandi F; Bellodi L
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating neuropsychiatric symptoms in dementia with Lewy bodies: a randomized controlled-trial.
    Culo S; Mulsant BH; Rosen J; Mazumdar S; Blakesley RE; Houck PR; Pollock BG
    Alzheimer Dis Assoc Disord; 2010; 24(4):360-4. PubMed ID: 20625270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
    Citrome L; Jaffe A; Levine J
    Schizophr Res; 2010 Jun; 119(1-3):153-9. PubMed ID: 20347267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperprolactinemia in an adolescent with psychotic disorder on risperidone.
    Jummani R; Coffey BJ
    J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):791-4. PubMed ID: 20035598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.